Tag: Australia’s

There has been a decline in the uptake of life-saving treatments among people living with hepatitis C, according to new data released by the Kirby Institute at UNSW Sydney. The data, released ahead of World Hepatitis Day on 28 July, shows that 58,280 people have begun hepatitis C therapy since highly-curative treatments were placed on

On-site testing of ‘party drug’ pills could reduce the harms caused by drug use and potentially save lives, according to an independent review of Australia’s National Drug Strategy, published in the open access Harm Reduction Journal. Dr Andrew Groves at Deakin University, Australia, examines evidence in support of pill testing to reduce fatalities caused by